Background Amongst the contributing factors of depression, vitamin D deficiency has increasingly drawn attention in recent years. This paper seeks to examine the association between serum vitamin D level and depression in patients with obesity. Methods In this comparative observational study, serum 25-hydroxyvitamin D [25(OH)D] levels were compared between obese individuals with depression (n = 174) and those without depression considering the effect of potential confounders. Participants were selected from males and females aged 18 to 60 years old visiting the outpatient obesity clinic of Rasoul-e Akram hospital, Tehran, Iran. The diagnosis of depressive disorder was made based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria. Additional clinical and laboratory data were collected from hospital electronic records. Mann–Whitney U test (nonparametric), Student’s t-test (parametric), and Chi-squared test were used to analyze the differences between the two groups. To examine age and gender differences in the relationship between vitamin D deficiency and depression, stratified analyses were conducted by age and gender groups. Results The mean 25(OH) D levels were significantly different between depressed and non-depressed groups (20 ± 15 vs. 27 ± 13, P < 0.001). Vitamin D insufficiency/deficiency was detected in 78 and 67% of the depressed and non-depressed groups, respectively, which was significantly different (P = 0.03). The associations between depression and the serum 25(OH) D levels were observed regardless of gender and age. The overall average vitamin D levels were not significantly different between total males and females (22 ± 13 vs. 23 ± 14, P = 0.49). The average level of vitamin D was higher in the older age group (40–60 years) compared to younger participants (18–39 years) (26 ± 15 vs. 21 ± 13, P = 0.004). Conclusion The present study provides additional evidence for the hypothesis that low vitamin D serum concentration is associated with depression in obese adults, and highlights the need for further research to determine whether this association is causal.
Background: Depression is one of the most prevalent psychiatric disorders reported in obese population. Amongst the contributing factors of depression, vitamin D deficiency has increasingly drawn attention in recent years. This paper seeks to examine the association between serum vitamin D level and depression in patients with obesity.Methods: This case-control study included 173 depressed obese patients and 174 non-depressed controls. Structured Clinical Interview for DSM-5 (SCID-5) was used to confirm the diagnosis of depression. 25-Hydroxyvitamin D [25(OH)D], Thyroid stimulating hormone (TSH), fasting blood sugar (FBS), parathyroid hormone (PTH) levels, and BMI were assessed in both groups. The statistical analyses included T-test, Chi-squared test, and multivariable logistic regression.Results: The mean 25(OH)D levels were significantly different between the case and control groups (20.43 ± 15.37 vs. 26.55 ± 13.17, P < .001). Vitamin D insufficiency/deficiency was detected in 77.6% and 67.4% of the case and control groups, respectively, which was significantly different (P = .034). Being female, greater age and lower vitamin D levels were associated with greater odds of developing depression (OR = 3.57, 95% CI = 1.82-7.02; OR = 1.05, 95% CI = 1.02-1.07; OR = 1.51, 95%CI = 1.16-1.96, respectively).Conclusion: The present study provides additional evidence with respect to the hypothesis that low vitamin D serum concentration is associated with depression in obese adults, and highlights the need for further research to determine whether this association is causal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.